RESUMO
BACKGROUND: Bloodstream infections (BSI) are a global health issue, leading to high mortality and morbidity among hospitalized patients. METHODS: A retrospective, observational and descriptive study was conducted by reviewing blood culture records collected from patients with suspected BSI, between January 2017 and December 2019. RESULTS: The most frequent antimicrobial resistant (AMR) pathogens were methicillin-resistantStaphylococcus aureus(MRSA) (40%), methicillin-resistantS. epidermidis (MRSE) (9.5%), and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (35.3%). CONCLUSIONS: Our findings underscore the importance of continued vigilance and advocate for the rational use of antimicrobial agents.
Assuntos
Anti-Infecciosos , Bacteriemia , Infecção Hospitalar , Staphylococcus aureus Resistente à Meticilina , Sepse , Humanos , Antibacterianos/farmacologia , Bacteriemia/microbiologia , beta-Lactamases , Brasil , Infecção Hospitalar/microbiologia , Farmacorresistência Bacteriana , Meticilina , Estudos Retrospectivos , Sepse/microbiologia , Centros de Atenção TerciáriaRESUMO
ABSTRACT Background: Bloodstream infections (BSI) are a global health issue, leading to high mortality and morbidity among hospitalized patients. Methods: A retrospective, observational and descriptive study was conducted by reviewing blood culture records collected from patients with suspected BSI, between January 2017 and December 2019. Results: The most frequent antimicrobial resistant (AMR) pathogens were methicillin-resistantStaphylococcus aureus(MRSA) (40%), methicillin-resistantS. epidermidis (MRSE) (9.5%), and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (35.3%). Conclusions: Our findings underscore the importance of continued vigilance and advocate for the rational use of antimicrobial agents.
